NCEL
NCEL
NASDAQ · Biotechnology

Newcelx Ltd

$2.12
+0.24 (+12.77%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,813.7% upside
Low Target $36.99
Average Target $40.57
High Target $64.99
Current Price $2.12
Current
$2.12
Target
$40.57
$36.99 $40.57 avg $64.99
Scenario Analysis
Bear Case
$36.99
1,644.8%
Low target
Base Case
$40.57
+1,813.7%
Avg target
Bull Case
$64.99
+2,965.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$30.80
-93.1% from high
52-Week Low
$1.89
+12.2% from low
Target vs 52W High
$40.57
+31.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%